Skip to main content


Save the date – Bacteriophage Symposium, Melbourne, 30th March, 2020

Hi everyone,
Happy New Years, I hope you all had a great break. I wanted to make a quick post to invite you all to attend a Bacteriophage Symposium that we will be hosting in Melbourne on the 30th March, 2020.

The Symposium will have a strong focus on phage therapy and its clinical translation, but will also have a talks on bacterial pathogenesis, fundamental phage biology and antibiotic resistance.

We are also pleased to announce that the Symposium will have plenary presentations from Prof. Robert 'Chip' Schooley and A/Prof. Saima Aslam from the Center for Innovative Phage Applications and Therapeutics (iPATH), at the University California, San Diego. We will also have a number of invited speakers from Australia, as well as a panel discussion that will broach phage therapy, its  challenges and potential in combating the antimicrobial resistance.

The Symposium will be free of charge, although attendees will be required to register for venue and catering purposes. We'd enc…
Recent posts

Update NHMRC & ARC profiles to include 'Bacteriophage' interest

Updated: 13th December, 2019
Hi SIG Members,

With grant season upon us I wanted to write a very brief post to encourage you all to update your RGMS (and more recently Sapphire) and RMS research profiles to include 'Bacteriophage' as a key research area. This was a suggestion from multiple SIG members to improve the quality of grant reviews, as many reviewers were non-phage experts.

In RGMS you can do this by logging in, selecting "My Profile & CV", then selecting "Edit my Profile and CV" and then selecting your RGMS profile. From here click the drop down menu under 'Properties' and select "Pro-RE: Research Interests" and then add in 'Bacteriophage' as a research keyword.

Update: To further nominate for a Panel Member again under the "Edit my Profile and CV" option, select your RGMS profile, from here click the drop down menu and select "Pro PN Panel Nominations", click 'New' to register interest for a…

ASM Annual General Meeting 2019 – Update

Thank you to everyone who attended and participated in the SIG’s Annual General Meeting (AGM) that was run at this years’ Australian Society for Microbiology (ASM) conference in Adelaide. A special thanks to Karen Weynberg and Carola Venturini for chairing and taking minutes for the meeting, respectively. Please see below a list of meeting notes from the AGM.

ASM Annual General Meeting – 1st July, 1-2pm

Dear SIG Members,

We would like to invite you all to attend our Annual General Meeting for the Bacteriophage Biology and Therapeutics SIG at the Adelaide ASM conference on July 1st, from 1-2pm in one of the lunch rooms (room details will be in ASM program).

Please see below a proposed agenda for the meeting. Karen Weynberg will be chairing the meeting.
We look forward to seeing you all there

Phage Futures Europe – 25-26th September, Belgium

Hi all,
I wanted to post a quick update to promote the upcoming Phage Futures Europe meeting, which will be held in Belgium from 25th-26th of September, 2019. The conference follows on from the very successful Phage Futures Congress held in Washington D.C. earlier this year and brings together academics, start-ups and pharma to discuss how to translate phage therapies. The organiser have kindly offered SIG members an extra 10% off  with the code – SIG10 – early bird registration ends this week.

Bacteriophage Biology & Therapeutics SIG – March 2019 Update

For the first Bacteriophage Biology & Therapeutics SIG posting of 2019, I would like to provide an update on the recent Microbiology Australia issue that focused on bacteriophages, highlight a number of relevant conferences and initiatives that may be of interest and provide some details on the SIG goals for 2019.

Phage in the Age of Synthetic Biology

By Karen Weynberg, CSIRO Synthetic Biology Fellow, School of Chemistry and Molecular Biosciences, Faculty of Science, University of Queensland
Synthetic biology is an emerging field of research set to revolutionise the future of biological science. To simply summarise synthetic biology can be challenging due to the myriad of tools, techniques and applications it encompasses. In essence, synthetic biology involves the use of engineering principles in a biological context. Using DNA-encoded componentry, synthetic biology enables the design and construction of biological parts, devices, cellular circuits and networks, and even whole organisms. This exciting new approach holds great promise for many areas of research, including biomedical efforts to treat cancer and other diseases, vaccine development, cell therapies, regenerative medicine and microbiome engineering.